Target intelligence / Profile preview

Bardet-Biedl syndrome 2 protein (BBS2)

Target
BBS2
Molecular classification
Other (BBSome subunit, chaperonin-like protein complex component)
01

Overview

Bardet-Biedl syndrome 2 protein (BBS2) is a core subunit of the BBSome, an octameric protein complex essential for primary cilia function and homeostasis[1][2][4][5][6]. The BBSome acts as a cargo adaptor, sorting and trafficking specific membrane proteins—such as G-protein coupled receptors (GPCRs)—to and from the ciliary membrane via the intraflagellar transport system[2][5][6]. BBS2 forms a dimer with BBS7 via a coiled-coil interaction and interacts with BBS9 through its α-helical domain, forming a critical assembly intermediate of the BBSome complex[1][4]. Mutations in BBS2 disrupt BBSome assembly, resulting in defective ciliary transport and the clinical manifestations of Bardet-Biedl syndrome, a genetically heterogeneous ciliopathy presenting with retinal dystrophy, obesity, polydactyly, renal abnormalities, and hypogenitalism, among other features[1][3][5]. Although fundamental to ciliary protein transport, there are no known pharmacological agents directly targeting BBS2 as a therapeutic approach. Pathogenic variants in BBS2 serve as diagnostic markers for Bardet-Biedl syndrome in clinical genetics[1][5].

Other names
BBSome complex member BBS2BBS2Bardet-Biedl syndrome 2 proteinBBSRP74
02

Biological functions

Ciliary protein transport and traffickingCiliogenesis (primary cilium biogenesis)Intraflagellar transport (IFT) assembly and regulationRegulation of membrane protein localization
03

Disease associations

Other (Ciliopathies)Bardet-Biedl syndrome (genetic, multisystem disorder)
04

Safety considerations

Pathogenic loss-of-function mutations may result in ciliopathies, including Bardet-Biedl syndrome, with systemic developmental and functional defects (e.g., retinal degeneration, obesity, polydactyly, renal anomalies)
05

Biomarkers

Pathogenic BBS2 mutations as genetic diagnostic markers for Bardet-Biedl syndrome

Beyond the preview

Go deeper on Bardet-Biedl syndrome 2 protein (BBS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bardet-Biedl syndrome 2 protein (BBS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call